Search

Your search keyword '"Manero, M."' showing total 341 results
Start Over Author "Manero, M."
341 results on '"Manero, M."'

13. Predicting post-operative atrial fibrillation after heart surgery: clinical profile and biomarkers

Author

Iglesias, D, primary, Rodriguez-Manero, M R M, additional, Fu, X F, additional, Martinez-Cereijo, J M C, additional, Agra-Bermejo, R A B, additional, Veiras-Del Rio, S V D R, additional, Taboada-Muniz, M T M, additional, Fernandez-Gonzalez, A F G, additional, Rivera-Caravaca, J M R C, additional, Lahoz, A L, additional, Arribas, J M A, additional, Canovas, S C, additional, Marin, F M, additional, Gonzalez-Juanatey, J R G J, additional, and Eiras-Penas, S E P, additional

Published
2023
Full Text
View/download PDF

14. Heart rate variability and syncope free survival after endocardial ablation of ganlionated plexi in patiens with recurrent vasovagal syncope and functional sinus node dysfunction and AV block

Author

Minguito Carazo, C, primary, Martinez Sande, J L, additional, Rodriguez Manero, M, additional, Garcia Seara, J, additional, Fernandez Lopez, X A, additional, Gonzalez Melchor, L, additional, Gonzalez Ferrero, T, additional, Garcia Rodeja, F, additional, Jimenez Ramos, V, additional, Martinon Martinez, J, additional, Sanchez Munoz, E, additional, and Gonzalez Juanatey, J R, additional

Published
2023
Full Text
View/download PDF

15. Impact of sodium-glucose cotransporter-2 (SLGT2) inhibitors treatment initiation on the reduction of atrial and ventricular arrhythmias in patients with implanted cardiac devices

Author

Minguito Carazo, C, primary, Sanchez Munoz, E, additional, Martinez Sande, J L, additional, Rodriguez Manero, M, additional, Fidalgo Andres, M L, additional, Garcia Seara, J, additional, Fernandez Lopez, X A, additional, Gonzalez Rebollo, J M, additional, Gonzalez Ferrero, T, additional, Rodriguez Santamarta, M, additional, Gonzalez Melchor, L, additional, Martinon Martinez, J, additional, Garcia Rodeja, F, additional, Fernandez Vazquez, F, additional, and Gonzalez Juanatey, J R, additional

Published
2023
Full Text
View/download PDF

22. DVT Management and Outcome Trends, 2001 to 2014

Author

Monreal, Manuel, Decousus, Hervè, Prandoni, Paolo, Brenner, Benjamin, Barba, Raquel, Di Micco, Pierpaolo, Bertoletti, Laurent, Schellong, Sebastian, Tzoran, Inna, Reis, Abilio, Bosevski, Marijan, Bounameaux, Henri, Malý, Radovan, Wells, Philip, Papadakis, Manolis, Agudo, P., Aibar, M.A., Akasbi, M., Alcalde-Manero, M., Andújar, V., Arcelus, J.I., Ballaz, A., Barba, R., Barrón, M., Barrón-Andrés, B., Bascuñana, J., Blanco-Molina, A., Cañas, I., Casado, I., de Miguel, J., del Toro, J., Díaz, S., Díaz-Peromingo, J.A., Falgá, C., Fernández-Capitán, C., Font, C., Font, L., Gallego, P., García-Bragado, F., García-Rodenas, M., Gómez, V., González, C.J., Grau, E., Guirado, L., Gutiérrez, J., Hernández, G., Hernández-Blasco, L., Isern, V., Jara-Palomares, L., Jaras, M.J., Jiménez, D., Lobo, J.L., López-Jiménez, L., López-Reyes, R., López-Sáez, J.B., Lorente, M.A., Lorenzo, A., Madridano, O., Maestre, A., Marchena, P.J., Martín, M., Martín-Antorán, J.M., Martín-Martos, F., Monreal, M., Morales, M.V., Nauffal, D., Nieto, J.A., Nieto, S., Núñez, M.J., Orbegoso, C., Otalora, S., Otero, R., Pagán, B., Pedrajas, J.M., Pérez, C., Pérez, G., Peris, M.L., Pons, I., Porras, J.A., Reig, O., Riera-Mestre, A., Rivas, A., Rodríguez, C., Rodríguez-Dávila, M.A., Rosa, V., Rosa-Murillo, A.S., Ruiz-Giménez, N., Sahuquillo, J.C., Sala, M.C., Sampériz, A., Sánchez, R., Sanz, O., Soler, S., Suriñach, J.M., Tolosa, C., Trujillo-Santos, J., Uresandi, F., Valero, B., Valle, R., Vela, J., Vidal, G., Vilar, C., Villalta, J., Xifre, B., Vanassche, T., Verhamme, P., Wells, P., Hirmerova, J., Malý, R., Tomko, T., Celis, G., Salgado, E., Sánchez, G.T., Bertoletti, L., Bura-Riviere, A., Farge-Bancel, D., Hij, A., Mahé, I., Merah, A., Quere, I., Papadakis, M., Braester, A., Brenner, B., Tzoran, I., Apollonio, A., Barillari, G., Bertone, A., Bilora, F., Bucherini, E., Ciammaichella, M., De Ciantis, P., Dentali, F., Di Micco, P., Duce, R., Ferrazzi, P., Grandone, E., Lessiani, G., Lodigiani, C., Mastroiacovo, D., Pace, F., Pesavento, R., Pinelli, M., Poggio, R., Prandoni, P., Rosa, M., Rota, L., Tiraferri, E., Tonello, D., Tufano, A., Venturelli, U., Visonà, A., Zalunardo, B., Drucka, E., Kigitovica, D., Skride, A., Mafalda, A., Ribeiro, J.L., Sousa, M.S., Bosevski, M., Zdraveska, M., Bounameaux, H., Mazzolai, L., Morillo, Raquel, Jiménez, David, Aibar, Miguel Ángel, Mastroiacovo, Daniela, Wells, Philip S., Sampériz, Ángel, Saraiva de Sousa, Marta, Muriel, Alfonso, and Yusen, Roger D.

Published
2016
Full Text
View/download PDF

23. Baseline profile and results of atrial fibrillation ablation in patients with arrhythmia-induced cardiomyopathy

Author

Gonzalez-Ferrero, T, primary, Minguito-Carazo, C, additional, Bergonti, M, additional, Lopez-Canoa, J N, additional, Garcia-Rodeja Arias, F, additional, Otero-Garcia, O, additional, Gonzalez-Maestro, A, additional, Martinez-Sande, J L, additional, Gonzalez-Melchor, L, additional, Garcia-Seara, J, additional, Fernandez-Lopez, J A, additional, Gonzalez-Juanatey, J R, additional, Sarkozy, A, additional, and Rodriguez-Manero, M, additional

Published
2022
Full Text
View/download PDF

26. Synergistic effect of a universal electronic consultation program and oral anticoagulation on outcomes in patients with atrial fibrillation

Author

Mazon Ramos, P, primary, Portela Romero, M, additional, Garcia Vega, D, additional, Rey-Aldana, D, additional, Rodriguez Manero, M, additional, Alvarez Alvarez, B, additional, Agra Bermejo, R, additional, Lage Fernandez, R, additional, Cinza Sanjurjo, S, additional, and Gonzalez Juanatey, J R, additional

Published
2022
Full Text
View/download PDF

27. Cholesterol remnants distribution in patients admitted for acute coronary syndrome

Author

Cordero, A, primary, Escribano, D, additional, Alvarez-Alvarez, B, additional, Martinon, J, additional, Garcia-Rondeja, F, additional, Rodriguez-Manero, M, additional, Bertomeu-Gonzalez, V, additional, Cazorla, D, additional, Moreno-Arribas, J, additional, Quintanilla, M A, additional, Lopez Ayala, J M, additional, Zuazola, P, additional, and Gonzalez-Juanatey, J R, additional

Published
2022
Full Text
View/download PDF

28. Effect on cholesterol remnants and residual lipid risk with PCSK9 inhibitors: the LIPID-REAL Registry

Author

Fernandez Del Olmo, R, primary, Cordero, A, additional, Cortez Quiroga, G, additional, Romero-Menor, C, additional, Facila, L, additional, Rondan, J, additional, Bello Mora, M C, additional, Sandin, M, additional, Valle, A, additional, Freixa, R, additional, Blanch, P, additional, Baneras, J, additional, Rodriguez-Manero, M, additional, and Gonzalez-Juanatey, J R, additional

Published
2022
Full Text
View/download PDF

31. Age as a prognostic modifier in anemic patients discharged after acute coronary syndrome

Author

Cazorla-Morallon, D, primary, Cordero, A, additional, Tomas-Simon, F J, additional, Sanchez-Munuera, S, additional, Alvarez-Alvarez, B, additional, Cid-Alvarez, B, additional, Garcia-Acuna, J M, additional, Rodriguez-Manero, M, additional, Escribano, D, additional, Bertomeu-Gonzalez, V, additional, Zuazola, P, additional, and Gonzalez-Juanatey, J R, additional

Published
2022
Full Text
View/download PDF

33. Arritmias

Author

Rodríguez-Mañero, M., Fernández López, A.X., García-Seara, J., Martínez-Sande, L., and González-Juanatey, J.R.

Published
2013
Full Text
View/download PDF

36. Effect of PCSK9 inhibitors on remnant cholesterol and lipid residual risk: The LIPID-REAL registry

Author

Cordero A, Fernandez Olmo M, Cortez Quiroga G, Romero-Menor C, Facila L, Seijas-Amigo J, Rondan Murillo J, Sandin M, Rodriguez-Manero M, Bello Mora M, Valle A, Fornovi A, Freixa Pamias R, Baneras J, Blanch Garcia P, Clemente Lorenzo M, Sanchez-Alvarez S, Lopez-Rodriguez L, and Gonzalez-Juanatey J

Subjects
remnants, PCSK9 inhibitors, triglycerides, residual risk
Abstract

Background Monoclonal antibodies that inhibit the proprotein convertase subtilisin/kexin type 9 (PCSK9) reduce low-density lipoprotein cholesterol (LDLc) by 55%, regardless of baseline treatments. Nonetheless, the effect of other lipid parameters, such as cholesterol remnants or, the so-called lipid residual risk, is unknown. Methods Multicenter and retrospective registry of patients treated with PCSK9 inhibitors from 14 different hospitals in Spain. Before and on-treatment lipid parameters were recorded. Residual lipid risk was estimated by (1) cholesterol remnants, (2) triglycerides/HDLc ratio (TG/HDL), (3) total cholesterol/HDLc (TC/HDL) and (4) the triglycerides-to-glucose index (TGGi). Results Six hundred fifty-two patients were analysed, mean age of 60.2 (9.63) years, 24.69% women and mean LDLc before treatment 149.24 (49.86) mg/dl. Median time to second blood determination was 187.5 days. On-treatment LDLc was 67.46 (45.78) mg/dl, which represented a 55% reduction. Significant reductions were observed for TG/HDL ratio, cholesterol remnants, TC/HDL ratio and TGGi. As consequence, 34.61% patients had LDLc 30 mg/dl before initiating the treatment with PCSK9 had higher reductions in cholesterol remnants, TG/HDL ratio, TC/HDL and TGGi. By contrast, no reduction differences were observed according to baseline LDLc (< or > the mean), age, gender or obesity. Conclusions This multicenter and retrospective registry of real-world patients treated with PCSK9 inhibitors demonstrates a positive effect on cholesterol remnants and lipid residual risk beyond LDLc reductions.

Published
2022

42. Direct Oral Anticoagulants Versus Vitamin-K Antagonist After PCIs in Patients With AF: A Meta-analysis of Cardiac Ischemic Events

Author

Cordero A, Ferreiro J, Bertomeu-Gonzalez V, Rodriguez-Manero M, Facila L, Escribano D, Sanchez-Recalde A, Zuazola P, Ruiz-Nodar J, and Gonzalez-Juanatey J

Subjects
vitamin-K antagonist, atrial fibrillation, PCI, DOACs
Abstract

Background: Clinical trials have assessed the effect of direct oral antagonists (DOACs) in patients with atrial fibrillation (AF) after percutaneous coronary interventions (PCI). Studies were designed to test the effect on bleeding incidence, but concerns related to safety on ischemic events remain. Methods: We performed a meta-analysis with currently available studies involving DOACs versus Vitamin-K antagonist (VKA) in patients with AF after PCI. The primary endpoint was the incidence of cardiac ischemic events, including myocardial infarction and stent thrombosis. Secondary endpoints were the incidence of stroke, all-cause mortality, and major bleeding. Results: Eleven thousand twenty-three patients were included in the analysis: 5510 receiving DOACs and 5513 VKA. A total of 190 cases of myocardial infarction were registered in patients treated with DOACs and 177 in patients on VKA, and no statistical difference was noted [relative risk (RR): 1.07 95% confidence interval (CI) 0.88-1.31]. The incidence of stent thrombosis was very low with no differences between both treatment strategies (RR: 1.14 95% CI 0.76-1.71). The incidence of cardiac ischemic events was the same in patients receiving DOACs or VKA (HR 1.09 95% CI 0.91-1.30). No differences were observed in the incidence of stroke (RR: 0.86 95% CI 0.61-1.23) or mortality (RR: 1.09, 95% CI 0.90-1.31). Treatment with DOACs was associated with 34% reduction in major bleeding (RR: 0.66, 95% CI 0.54-0.81). Conclusions: Treatment with DOACs in patients with AF after a PCI do not increase the risk of cardiac ischemic events, stroke, or death and reduce the incidence of major bleeding by 34% as compared with VKA.

Published
2021

43. New-onset heart failure after acute coronary syndrome in patients without heart failure or left ventricular dysfunction

Author

Cordero A, Rodriguez-Manero M, Bertomeu-Gonzalez V, Garcia-Acuna J, Baluja A, Agra-Bermejo R, Alvarez-Alvarez B, Cid B, Zuazola P, and Gonzalez-Juanatey J

Subjects
Beta-blockers, Revascularization, Heart failure, Acute coronary syndrome
Abstract

Introduction and objectives: Coronary heart disease is the leading cause of heart failure (HF). The aim of this study was to assess the risk of readmission for HF in patients with acute coronary syndrome without previous HF or left ventricular dysfunction. Methods: Prospective study of consecutive patients admitted for acute coronary syndrome in 2 institutions. Risk factors for HF were analyzed by competing risk regression, taking all-cause mortality as a competing event. Results: We included 5962 patients and 567 (9.5%) experienced at least 1 hospital readmission for acute HF. Median follow-up was 63 months and median time to HF readmission was 27.1 months. The cumulative incidence of HF was higher than mortality in the first 7 years after hospital discharge. A higher risk of HF readmission was associated with age, diabetes, previous coronary heart disease, GRACE score > 140, peripheral arterial disease, renal dysfunction, hypertension and atrial fibrillation; a lower risk was associated with optimal medical treatment. The incidence of HF in the first year of follow-up was 2.73% and no protective variables were found. A simple HF risk score predicted HF readmissions risk. Conclusions: One out of 10 patients discharged after an acute coronary syndrome without previous HF or left ventricular dysfunction had new-onset HF and the risk was higher than the risk of mortality. A simple clinical score can estimate individual risk of HF readmission even in patients without previous HF or left ventricular dysfunction. (C) 2020 Sociedad Espanola de Cardiologia. Published by Elsevier Espana, S.L.U. All rights reserved.

Published
2021

44. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

Author

Riera-Mestre, A, Mora-Lujan, JM, Trujillo-Santos, J, Del Toro, J, Nieto, JA, Pedrajas, JM, Lopez-Reyes, R, Soler, S, Ballaz, A, Cerda, P, Monreal, M, Prandoni, P, Brenner, B, Farge-Bancel, D, Barba, R, Di Micco, P, Bertoletti, L, Schellong, S, Tzoran, I, Reis, A, Bosevski, M, Bounameaux, H, Maly, R, Verhamme, P, Caprini, JA, Bui, HM, Adarraga, MD, Agud, M, Aibar, MA, Alcalde-Manero, M, Alfonso, J, Amado, C, Arcelus, JI, Barbagelata, C, Barron, M, Barron-Andres, B, Blanco-Molina, A, Camon, AM, Canas, I, Castro, J, de Miguel, J, del Toro, J, Demelo, P, Diaz-Pedroche, C, Diaz-Peromingo, JA, Dominguez, I, Escribano, JC, Falga, C, Fernandez-Capitan, C, Fernandez-Criado, MC, Fidalgo, MA, Flores, K, Font, C, Font, L, Furest, I, Garcia, MA, Garcia-Bragado, F, Garcia-Raso, A, Gavin-Bianco, O, Gavin-Sebastian, O, Gil-Diaz, A, Godoy-Diaz, D, Gomez, V, Gomez-Cuelvo, C, Gonzalez-Martinez, J, Grau, E, Guirado, L, Gutierrez, J, Hernandez-Blasco, LM, Jara-Palomares, L, Jaras, MJ, Jimenez, D, Joya, MD, Jou, I, Lalueza, A, Lecumberri, R, Lima, J, Llamas, P, Lobo, JL, Lopez-Jimenez, L, Lopez-Meseguer, M, Lopez-Miguel, P, Lopez-Nunez, JJ, Lopez-Saez, JB, Lorente, MA, Loring, M, Lumbierres, M, Madridano, O, Maestre, A, Marchena, PJ, Martin-Martos, F, Martinez-Baquerizo, C, Martinez-Garcia, MA, Mellado, M, Moises, J, Morales, MV, Munoz-Bianco, A, Nunez, MJ, Olivares, MC, Olivera, PE, Ortega, C, Osorio, J, Otalora, S, Otero, R, Panadero-Macia, M, Parra, V, Pellejero, G, Perez-Ductor, C, Perez-Rus, G, Penis, ML, Pesantez, D, Porras, JA, Rivas, A, Rodriguez-Cobo, A, Rodriguez-Matute, C, Rosa, V, Rubio, CM, Ruiz-Artacho, P, Ruiz-Sada, P, Sahuquillo, JC, Sala-Sainz, MC, Salgueiro, G, Samperiz, A, Sanchez-Martinez, R, Sanchez-Munoz-Torrero, JF, Segui, E, Suarez, S, Surinach, JM, Tolosa, C, Torres, MI, Uresandi, F, Valero, B, Valle, R, Vidal, G, Aar, C, Villares, P, Gutierrez, P, Vazquez, FJ, Vilaseca, A, Vanassche, T, Vandenbriele, C, Hirmerova, J, Salgado, E, Benzidia, I, Bura-Riviere, A, Debourdeau, P, Courtois, MC, Helfer, H, Hij, A, Mahe, I, Moustafa, F, Braester, A, Bilora, F, Bortoluzzi, C, Ciammaichella, M, Dentali, F, Fermi, P, Imbaizano, E, Lodigiani, C, Maida, R, Mastroiacovo, D, Mumoli, N, Pace, F, Pesavento, R, Pomero, F, Quintavalla, R, Rocci, A, Rota, L, Siniscalchi, C, Tiraferri, E, Tufano, A, Visona, A, Hong, NV, Zalunardo, B, Kalejs, RV, Kigitovica, D, Skride, A, Zdraveska, M, Mazzola, L, Capnini, JA, Tafur, AJ, Vanassche, T, Verhamme, P, Riera-Mestre, A., Mora-Lujan, J. M., Trujillo-Santos, J., Del Toro, J., Nieto, J. A., Pedrajas, J. M., Lopez-Reyes, R., Soler, S., Ballaz, A., Cerda, P., Monreal, M., Prandoni, P., Brenner, B., Farge-Bancel, D., Barba, R., Di Micco, P., Bertoletti, L., Schellong, S., Tzoran, I., Reis, A., Bosevski, M., Bounameaux, H., Maly, R., Verhamme, P., Caprini, J. A., Bui, H. M., Adarraga, M. D., Agud, M., Aibar, M. A., Alcalde-Manero, M., Alfonso, J., Amado, C., Arcelus, J. I., Barbagelata, C., Barron, M., Barron-Andres, B., Blanco-Molina, A., Camon, A. M., Canas, I., Castro, J., De Miguel, J., Demelo, P., Diaz-Pedroche, C., Diaz-Peromingo, J. A., Dominguez, I. M., Escribano, J. C., Falga, C., Fernandez-Capitan, C., Fernandez-Criado, M. C., Fidalgo, M. A., Flores, K., Font, C., Font, L., Furest, I., Garcia, M. A., Garcia-Bragado, F., Garcia-Raso, A., Gavin-Blanco, O., Gavin-Sebastian, O., Gil-Diaz, A., Godoy-Diaz, D., Gomez, V., Gomez-Cuervo, C., Gonzalez-Martinez, J., Grau, E., Guirado, L., Gutierrez, J., Hernandez-Blasco, L. M., Jara-Palomares, L., Jaras, M. J., Jimenez, D., Joya, M. D., Jou, I., Lalueza, A., Lecumberri, R., Lima, J., Llamas, P., Lobo, J. L., Lopez-Jimenez, L., Lopez-Meseguer, M., Lopez-Miguel, P., Lopez-Nunez, J. J., Lopez-Saez, J. B., Lorente, M. A., Loring, M., Lumbierres, M., Madridano, O., Maestre, A., Marchena, P. J., Martin-Martos, F., Martinez-Baquerizo, C., Martinez-Garcia, M. A., Mellado, M., Moises, J., Morales, M. V., Munoz-Blanco, A., Nunez, M. J., Olivares, M. C., Olivera, P. E., Ortega, C., Osorio, J., Otalora, S., Otero, R., Panadero-Macia, M., Parra, V., Pellejero, G., Perez-Ductor, C., Perez-Rus, G., Peris, M. L., Pesantez, D., Porras, J. A., Rivas, A., Rodriguez-Cobo, A., Rodriguez-Matute, C., Rosa, V., Rubio, C. M., Ruiz-Artacho, P., Ruiz-Sada, P., Sahuquillo, J. C., Sala-Sainz, M. C., Salgueiro, G., Samperiz, A., Sanchez-Martinez, R., Sanchez-Munoz-Torrero, J. F., Segui, E., Suarez, S., Surinach, J. M., Tolosa, C., Torres, M. I., Uresandi, F., Valero, B., Valle, R., Vidal, G., Vilar, C., Villares, P., Gutierrez, P., Vazquez, F. J., Vilaseca, A., Vanassche, T., Vandenbriele, C., Hirmerova, J., Salgado, E., Benzidia, I., Bura-Riviere, A., Debourdeau, P., Courtois, M. C., Helfer, H., Hij, A., Mahe, I., Moustafa, F., Braester, A., Bilora, F., Bortoluzzi, C., Ciammaichella, M., Dentali, F., Ferrazzi, P., Imbalzano, E., Lodigiani, C., Maida, R., Mastroiacovo, D., Mumoli, N., Pace, F., Pesavento, R., Pomero, F., Quintavalla, R., Rocci, A., Rota, L., Siniscalchi, C., Tiraferri, E., Tufano, A., Visona, A., Vo Hong, N., Zalunardo, B., Kalejs, R. V., Kigitovica, D., Skride, A., Zdraveska, M., Mazzolai, L., and Tafur, A. J.

Subjects
0301 basic medicine, Registrie, lcsh:Medicine, 030105 genetics & heredity, Research & Experimental Medicine, THERAPY, 0302 clinical medicine, Pharmacology (medical), Registries, Telangiectasia, EPISTAXIS, Genetics (clinical), Venous Thrombosis, Embòlia pulmonar, Genetics & Heredity, OUTCOMES, FACTOR-VIII, General Medicine, Heparin, Hemorrhagic hereditary telangiectasia, Middle Aged, Pulmonary embolism, Rare diseases, Natural history, Venous thrombosis, Medicine, Research & Experimental, Deep venous thrombosis, Telangiectasia, Hereditary Hemorrhagic, medicine.symptom, Malalties rares, Life Sciences & Biomedicine, medicine.drug, Human, Venous thromboembolism, Adult, medicine.medical_specialty, Hemorrhage, Therapeutics, HHT, 03 medical and health sciences, Internal medicine, medicine, Humans, cardiovascular diseases, Risk factor, Deep venous thrombosi, Aged, Tromboflebitis, Bleeding episodes, Science & Technology, business.industry, Research, lcsh:R, Thrombophlebitis, medicine.disease, Terapèutica, equipment and supplies, business, Rare disease, 030217 neurology & neurosurgery, RENDU-OSLER-WEBER
Abstract

BACKGROUND: Limited data exist about the clinical presentation, ideal therapy and outcomes of patients with hereditary hemorrhagic telangiectasia (HHT) who develop venous thromboembolism (VTE). METHODS: We used the data in the RIETE Registry to assess the clinical characteristics, therapeutic approaches and clinical outcomes during the course of anticoagulant therapy in patients with HHT according to initial presentation as pulmonary embolism (PE) or deep venous thrombosis (DVT). RESULTS: Of 51,375 patients with acute VTE enrolled in RIETE from February 2009 to January 2019, 23 (0.04%) had HHT: 14 (61%) initially presented with PE and 9 (39%) with DVT alone. Almost half (47.8%) of the patients with VTE had a risk factor for VTE. Most PE and DVT patients received low-molecular-weight heparin for initial (71 and 100%, respectively) and long-term therapy (54 and 67%, respectively). During anticoagulation for VTE, the rate of bleeding events (major 2, non-major 6) far outweighed the rate of VTE recurrences (recurrent DVT 1): 50.1 bleeds per 100 patient-years (95%CI: 21.6-98.7) vs. 6.26 recurrences (95%CI: 0.31-30.9; p = 0.020). One major and three non-major bleeding were epistaxis. No patient died of bleeding. One patient died shortly after being diagnosed with acute PE. CONCLUSIONS: During anticoagulation for VTE in HHT patients, there were more bleeding events than VTE recurrences. Most bleeding episodes were non-major epistaxis. ispartof: ORPHANET JOURNAL OF RARE DISEASES vol:14 issue:1 ispartof: location:England status: published

Published
2019

45. Leadless pacemaker implant with concomitant atrioventricular node ablation: a single center study with longterm followup

Author

Martinez Sande, JL, primary, Garcia-Seara, J, additional, Gonzalez-Melchor, L, additional, Rodriguez-Manero, M, additional, Torrelles-Fortuny, A, additional, Perez-Poza, M, additional, Abou-Jokh, C, additional, Gonzalez-Ferrero, T, additional, Garcia-Vega, D, additional, Fernandez-Lopez, XA, additional, and Gonzalez-Juanatey, JR, additional

Published
2021
Full Text
View/download PDF

46. Result of electrophysiological study in patients with undocumented suspected paroxysmal supraventricular tachycardia: the BELIEVE-SVT registry

Author

Ramos Jimenez, J, primary, Marco Del Castillo, A, additional, Lozano Granero, VC, additional, Ramos Fernandez, P, additional, Jimenez Sanchez, D, additional, Gunturiz Beltran, C, additional, Alonso Fernandez, P, additional, Ayala, HD, additional, Dallaglio, P, additional, Salgado, R, additional, Lazaro Rivera, C, additional, Rodriguez Manero, M, additional, Borrego Bernabe, L, additional, Arribas Ynsaurriaga, F, additional, and Rodriguez Munoz, DA, additional

Published
2021
Full Text
View/download PDF

47. Recurrence of palpitations following electrophysiological study and ablation in suspected but undocumented paroxysmal supraventricular tachycardias: follow-up results of the BELIEVE-SVT registry

Author

Marco Del Castillo, A, primary, Ramos Jimenez, J, additional, Lozano Granero, VC, additional, Rodriguez Manero, M, additional, Ramos Fernandez, P, additional, Lazaro Rivera, C, additional, Jimenez Sanchez, D, additional, Ayala, HD, additional, Dallaglio, P, additional, Alonso Fernandez, P, additional, Salgado, R, additional, Gunturiz Beltran, C, additional, Fontenla Cerezuela, AR, additional, Arribas Ynsaurriaga, F, additional, and Rodriguez Munoz, DA, additional

Published
2021
Full Text
View/download PDF

48. Clinical recurrence of palpitations following slow pathway ablation in patients with suspected paroxysmal supraventricular tachycardias but non-documented, non-inducible tachycardias

Author

Ramos Jimenez, J, primary, Marco Del Castillo, A, additional, Lozano Granero, VC, additional, Lazaro Rivera, C, additional, Salgado, R, additional, Rodriguez Manero, M, additional, Ramos Fernandez, P, additional, Dallaglio, P, additional, Gunturiz Beltran, C, additional, Alonso Fernandez, P, additional, Ayala, HD, additional, Jimenez Sanchez, D, additional, Lopez Gil, M, additional, Arribas Ynsaurriaga, F, additional, and Rodriguez Munoz, DA, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results